Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Andreas Pfützner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Microcirculation

Anatomy

Insulin-Secreting Cells

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
97
Forst, Thomas
28
Kann, Peter
26
Beyer, Jürgen
24
Kunt, Thomas
22
Lübben, Georg
21
Hohberg, Cloth
20
Löbig, Mirjam
16
Schöndorf, Thomas
15
Engelbach, M
14
Weber, Matthias
10
Karagiannis, Efstrathios
10
Larbig, Martin
9
Forst, Senait
7
Hanefeld, Markolf
7
Langenfeld, Matthias

Sign-in to see all Coauthors

Publications

TOP 3
Meyer Silke; Schaefer Stephan; Stolk Lisette; Arp Pascal; Uitterlinden André G; Plöckinger Ursula; Stalla Günter K; Tuschy Ulrich; Weber Matthias M; Weise Alexander; Pfützner Andreas; Kann Peter H
Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
Pfützner A; Forst T
Intensification with prandial insulin.
Schöndorf Thomas; Karagiannis Efstrathios; Posseldt Richard E K; Forst Thomas; Pfützner Andreas
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Andreas Pfützner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Meyer Silke; Schaefer Stephan; Stolk Lisette; Arp Pascal; Uitterlinden André G; Plöckinger Ursula; Stalla Günter K; Tuschy Ulrich; Weber Matthias M; Weise Alexander; Pfützner Andreas; Kann Peter H
Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
Pharmacogenomics 2009;10(10):1599-608.
2009: Pfützner A; Forst T
Intensification with prandial insulin.
International journal of clinical practice. Supplement 2009;(164):11-4.
2009: Schöndorf Thomas; Karagiannis Efstrathios; Posseldt Richard E K; Forst Thomas; Pfützner Andreas
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.
Diabetes technology & therapeutics 2009;11(6):379-83.
2009: Hohberg C; Pfützner A; Forst T; Lübben G; Karagiannis E; Borchert M; Schöndorf T
Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.
Diabetes, obesity & metabolism 2009;11(5):464-71.
2009: Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann P H; Karagiannis E; Wilhelm B; Forst T
Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(3):202-6.
2009: Forst Thomas; Hohberg Cloth; Schöndorf Thomas; Borchert Marcus; Forst Senait; Roth Werner; Dehos Barbara; Pfützner Andreas
Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.
Diabetes technology & therapeutics 2009;11(2):87-92.
2009: Forst T; Hohberg C; Pfützner A
Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(2):123-31.
2009: Meyer Silke; Schaefer Stephan; Ivan Diana; Stolk Lisette; Arp Pascal; Uitterlinden André G; Nawroth Peter P; Plöckinger Ursula; Stalla Günter K; Tuschy Ulrich; Weber Matthias M; Weise Alexander; Pfützner Andreas; Kann Peter H
Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.
Pharmacogenomics 2009;10(2):293-302.
2009: Pfützner Andreas; Efstrathios Karagiannis; Löbig Mirjam; Armbruster Franz Paul; Hanefeld Markolf; Forst Thomas
Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study.
Clinical laboratory 2009;55(7-8):275-81.
2009: Safinowski Michael; Wilhelm Birgit; Reimer Tanja; Weise Alexander; Thomé Nicole; Hänel Heike; Forst Thomas; Pfützner Andreas
Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(4):483-8.
2008: Reimer Tanja; Hohberg Cloth; Pfützner Anke H; Jørgensen Christina; Jensen Klaus H; Pfützner Andreas
Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Clinical therapeutics 2008;30(12):2252-62.
2008: Forst Thomas; Hohberg Cloth; Tarakci Eda; Forst Senait; Kann Peter; Pfützner Andreas
Reliability of Lightguide Spectrophotometry (O2C) for the Investigation of Skin Tissue Microvascular Blood Flow and Tissue Oxygen Supply in Diabetic and Nondiabetic Subjects.
Journal of diabetes science and technology 2008;2(6):1151-6.
2008: Forst Thomas; Wilhelm Birgit; Pfützner Andreas; Fuchs Winfried; Lehmann Ute; Schaper Frank; Weber Matthias; Müller Jürgen; Konrad Thomas; Hanefeld Markolf
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(4):298-303.
2008: Leonhardt Wolfgang; Pfützner Andreas; Müller Jürgen; Pietzsch Jens; Forst Thomas; Karagiannis Efstrathios; Lübben Georg; Hanefeld Markolf
Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.
Atherosclerosis 2008;201(1):155-62.
2008: Pfützner A; Reimer T; Hohberg C; Frøkjaer L P F; Jørgensen C
Prefilled insulin device with reduced injection force: patient perception and accuracy.
Current medical research and opinion 2008;24(9):2545-9.
2008: Pfützner A; Asakura T; Sommavilla B; Lee Wc
Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
Expert opinion on drug delivery 2008;5(8):915-25.
2008: Meyer Silke; Haist Marlitt; Schaefer Stephan; Ivan Diana; Ittner Jochen R; Nawroth Peter P; Plöckinger Ursula; Stalla Günter K; Tuschy Ulrich; Weber Matthias M; Weise Alexander; Pfützner Andreas; Habbe Nils; Kann Peter H
Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults.
Pharmacogenomics 2008;9(8):1017-26.
2008: Karagiannis Efstrathios; Pfützner Andreas; Forst Thomas; Lübben Georg; Roth Werner; Grabellus Martin; Flannery Manja; Schöndorf Thomas
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions.
Diabetes technology & therapeutics 2008;10(3):206-12.
2008: Hänel Heike; Weise Alexander; Sun Wei; Pfützner Johannes W; Thomé Nicole; Pfützner Andreas
Differences in the dose accuracy of insulin pens.
Journal of diabetes science and technology 2008;2(3):478-81.
2008: Hohberg Clothilde; Forst Thomas; Larbig Martin; Safinowski Michael; Diessel Stefan; Hehenwarter Silvia; Weber Matthias M; Schöndorf Thomas; Pfützner Andreas
Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.
Diabetes care 2008;31(5):1021-5.
2008: Schöndorf Thomas; Pfützner Andreas; Lübben Georg; Karagiannis Efstrathios; Roth Werner; Forst Thomas
Pioglitazone Improves Metabolic Markers in Patients with Type 2 Diabetes Independently from Physical Activities: Results from the IRIS III Study.
Journal of diabetes science and technology 2008;2(2):244-9.
2008: Forst T; Karagiannis E; Lübben G; Hohberg C; Schöndorf T; Dikta G; Drexler M; Morcos M; Dänschel W; Borchert M; Pfützner A
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
Atherosclerosis 2008;197(1):311-7.
2008: Pfützner Andreas; Weber Matthias M; Forst Thomas
A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus.
Clinical laboratory 2008;54(11-12):485-90.
2008: Pfützner A; Marx N; Walcher D; Löbig M; Seidel D; Forst T
Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.
Clinical laboratory 2008;54(7-8):237-41.
2008: Dahmen Norbert; Manderscheid Nina; Helfrich Jana; Musholt Petra B; Forst Thomas; Pfützner Andreas; Engel Alice
Elevated peripheral visfatin levels in narcoleptic patients.
PloS one 2008;3(8):e2980.
2008: Hach Thomas; Forst Thomas; Kunt Thomas; Ekberg Karin; Pfützner Andreas; Wahren John
C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.
Experimental diabetes research 2008;2008():730594.
2008: Wilhelm B; Kann P; Pfützner A
Influence of C-peptide on glucose utilisation.
Experimental diabetes research 2008;2008():769483.
2007: Kunt Thomas; Forst Thomas; Kazda Christof; Harzer Oliver; Engelbach Martin; Löbig Mirjam; Beyer Jürgen; Pfützner Andreas
The beta-Specific Protein Kinase C Inhibitor Ruboxistaurin (LY333531) Suppresses Glucose-Induced Adhesion of Human Monocytes to Endothelial Cells in Vitro.
Journal of diabetes science and technology 2007;1(6):929-35.
2007: Pfützner A; Hanefeld M; Lübben G; Weber M M; Karagiannis E; Köhler C; Hohberg C; Forst T
Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2007;39(10):764-8.
2007: Borchert M; Schöndorf T; Lübben G; Forst T; Pfützner A
Review of the pleiotropic effects of peroxisome proliferator-activated receptor gamma agonists on platelet function.
Diabetes technology & therapeutics 2007;9(5):410-20.
2007: Rave Klaus; Heise Tim; Pfützner Andreas; Boss Anders H
Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
Diabetes care 2007;30(9):2307-8.
2007: Petrak Frank; Stridde Elmar; Leverkus Friedhelm; Crispin Alexander A; Forst Thomas; Pfützner Andreas
Development and validation of a new measure to evaluate psychological resistance to insulin treatment.
Diabetes care 2007;30(9):2199-204.
2007: Dahmen Norbert; Engel Alice; Helfrich Jana; Manderscheid Nina; Löbig Mirjam; Forst Thomas; Pfützner Andreas; Tonn Peter
Peripheral leptin levels in narcoleptic patients.
Diabetes technology & therapeutics 2007;9(4):348-53.
2007: Pfützner Andreas; Weber Matthias M; Forst Thomas
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.
Expert opinion on pharmacotherapy 2007;8(12):1985-98.
2007: Wilhelm Birgit; Weber Matthias M; Kreisselmeier Hans Peter; Kugler Matthias; Ries Claudius; Pfützner Andreas; Kann Peter H; Forst Thomas
Endothelial Function and Arterial Stiffness in Uncomplicated Type 1 Diabetes and Healthy Controls and the Impact of Insulin on These Parameters during an Euglycemic Clamp.
Journal of diabetes science and technology 2007;1(4):582-9.
2007: Forst Thomas; Smith Terry; Schütte Klemens; Marcus Paul; Pfützner Andreas;
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.
British journal of clinical pharmacology 2007;64(1):75-82.
2007: Schöndorf Thomas; Lübben Georg; Hoopmann Markus; Borchert Marcus; Forst Thomas; Hohberg Cloth; Löbig Mirjam; Armbruster Franz-Paul; Roth Werner; Grabellus Martin; Pfützner Andrzas
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2007;23(6):356-60.
2007: Weinand Frank; Jung Annette; Stein Alexandra; Pfützner Andreas; Becker Ralph; Pavlovic Sima
Rotational stability of a single-piece hydrophobic acrylic intraocular lens: new method for high-precision rotation control.
Journal of cataract and refractive surgery 2007;33(5):800-3.
2007: Forst Thomas; Pfützner Andreas; Lübben Georg; Weber Matthias; Marx Nikolaus; Karagiannis Efstrathios; Koehler Carsta; Baurecht Werner; Hohberg Cloth; Hanefeld Markolf
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
Metabolism: clinical and experimental 2007;56(4):491-6.
2007: Wilhelm Birgit; Klein Johannes; Friedrich Christiane; Forst Senait; Pfützner Andreas; Kann Peter H; Weber Matthias M; Forst Thomas
Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and nondiabetic subjects with cardiovascular disease.
Journal of diabetes science and technology 2007;1(2):260-3.
2007: Mohr Thomas A; Pfützner Andreas; Forst Senait; Forst Thomas; Schöndorf Thomas
Self-Monitoring of Blood Glucose Levels Requires Intensive Training for use of Meters to Obtain Reliable and Clinically Relevant Measurements.
Journal of diabetes science and technology 2007;1(1):56-61.
2007: Hanefeld Markolf; Marx Nikolaus; Pfützner Andreas; Baurecht Werner; Lübben Georg; Karagiannis Efstrathios; Stier Ulf; Forst Thomas
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Journal of the American College of Cardiology 2007;49(3):290-7.
2007: Pfützner Andreas; Wilhelm Birgit; Forst Thomas
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination.
Vascular health and risk management 2007;3(2):211-20.
2007: Schöndorf Thomas; Forst Thomas; Hohberg Cloth; Lübben Georg; Armbruster Franz Paul; Roth Werner; Borchert Marcus; Köder Christiane; Löbig Mirjam; Grabellus Martin; Pfützner Andreas
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.
Clinical laboratory 2007;53(3-4):193-8.
2006: Forst T; Pfützner A
[Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others]
Deutsche medizinische Wochenschrift (1946) 2006;131 Suppl 8():S268-73.
2006: Hille Stephanie; Rein Daniel T; Riffelmann Marion; Neumann Rainer; Sartorius Judith; Pfützner Andreas; Kurbacher Christian M; Schöndorf Thomas; Breidenbach Martina
Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer.
Anti-cancer drugs 2006;17(9):1041-4.
2006: Pfützner J; Forst T; Butzer R; Forst S; Weber M M; Pfützner A H; Pfützner A
Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(10):1124-9.
2006: Pfützner J; Forst T; Butzer R; Forst S; Weber M M; Pfützner A H; Pfützner A
Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(10):1124-9.
2006: Pfützner Andreas; Schneider Christian A; Forst Thomas
Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects.
Expert review of cardiovascular therapy 2006;4(4):445-59.
2006: Pfützner Andreas; Lorra Babette; Abdollahnia Michel R; Kann Peter H; Mathieu Dominik; Pehnert Christine; Oligschleger Christina; Kaiser Marcel; Forst Thomas
The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
Diabetes technology & therapeutics 2006;8(3):375-84.
2006: Wilhelm Birgit; Forst Senait; Weber Matthias M; Larbig Martin; Pfützner Andreas; Forst Thomas
Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetes.
Diabetes technology & therapeutics 2006;8(2):146-55.
2006: Pfützner Andreas; Forst Thomas
Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality.
Expert opinion on pharmacotherapy 2006;7(4):463-76.
2006: Forst T; Caduff A; Talary M; Weder M; Brändle M; Kann P; Flacke F; Friedrich Ch; Pfützner A
Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetes.
Diabetes technology & therapeutics 2006;8(1):94-101.
2006: Pfützner Andreas; Forst Thomas
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus.
Diabetes technology & therapeutics 2006;8(1):28-36.
2006: Pfützner Andreas; Schöndorf Thomas; Seidel Daniela; Winkler Karl; Matthaei Stephan; Hamann Andreas; Forst Thomas
Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.
Metabolism: clinical and experimental 2006;55(1):20-5.
2006: Weise A; Lambertz U; Thomé N; Bartz U; Krefft M; Mockenhaupt F; Bienzle U; Schöndorf T; Forst T; Pfützner A
A fast and reliable single-run method for genotyping of the human cytochrome P450 2C8 gene for different ethnic groups.
Clinical laboratory 2006;52(11-12):599-603.
2006: Pfützner Andreas; Standl Eberhard; Strotmann Hermann-Josef; Schulze Jan; Hohberg Cloth; Lübben Georg; Pahler Sabine; Schöndorf Thomas; Forst Thomas
Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(5):556-60.
2005: Röwer Susanne; Bienzle Ulrich; Weise Alexander; Lambertz Ulrike; Forst Thomas; Otchwemah Rowland N; Pfützner Andreas; Mockenhaupt Frank P
Short communication: high prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana.
Tropical medicine & international health : TM & IH 2005;10(12):1271-3.
2005: Pfützner Andreas; Forst Thomas
Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
Expert opinion on drug delivery 2005;2(6):1097-106.
2005: Forst Thomas; Lübben Georg; Hohberg Clothilde; Kann Peter; Sachara Christian; Gottschall Volker; Friedrich Christiane; Rosskopf Reiner; Pfützner Andreas
Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.
Microcirculation (New York, N.Y. : 1994) 2005;12(7):543-50.
2005: Forst T; Hohberg C; Fuellert S D; Lübben G; Konrad T; Löbig M; Weber M M; Sachara C; Gottschall V; Pfützner A
Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2005;37(8):521-7.
2005: Pfützner A; Hohberg C; Lübben G; Pahler S; Pfützner A H; Kann P; Forst T
Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2005;37(8):510-5.
2005: Pfützner A; Hohberg C; Lübben G; Pahler S; Pfützner A H; Kann P; Forst T
Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2005;37(8):510-5.
2005: Pfützner Andreas; Marx Nikolaus; Lübben Georg; Langenfeld Matthias; Walcher Daniel; Konrad Thomas; Forst Thomas
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study.
Journal of the American College of Cardiology 2005;45(12):1925-31.
2005: Pfützner Andreas; Standl Eberhard; Hohberg Cloth; Konrad Thomas; Strotmann Hermann-Josef; Lübben Georg; Langenfeld Matthias R; Schulze Jan; Forst Thomas
IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.
Diabetes technology & therapeutics 2005;7(3):478-86.
2005: Langenfeld M R; Forst T; Hohberg C; Kann P; Lübben G; Konrad T; Füllert S D; Sachara C; Pfützner A
Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.
Circulation 2005;111(19):2525-31.
2005: Forst Thomas; Forst Senait; Strunk Klaudia; Löbig Miriam; Welter Kathi; Kazda Christof; Pfützner Andreas
Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
Journal of diabetes and its complications 2005;19(3):128-32.
2005: Pfützner A; Kerner W
[Pitfalls in the diagnosis and treatment optimization of type 2 diabetes]
MMW Fortschritte der Medizin 2005;147(12):47-50.
2005: Schöndorf Thomas; Maiworm Agnes; Emmison Neil; Forst Thomas; Pfützner Andreas
Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk.
Clinical laboratory 2005;51(9-10):489-94.
2005: Pfützner A; Pfützner A H; Kann P H; Stute R; Löbig M; Yang J W; Mistry J; Forst T
Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.
Clinical laboratory 2005;51(5-6):243-9.
2005: Pfützner A; Pfützner A H; Kann P H; Stute R; Löbig M; Yang J W; Mistry J; Forst T
Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.
Clinical laboratory 2005;51(5-6):243-9.
2004: Langenfeld Matthias R; Forst Thomas; Standl Eberhard; Strotmann Hermann-Josef; Lübben Georg; Pahler Sabine; Kann Peter; Pfützner Andreas;
IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance.
Diabetes technology & therapeutics 2004;6(6):836-43.
2004: Nguyen Mai; Henniges Wolfgang; Lobisch Michael; Reifert Silvia; Larbig Martin; Pfützner Andreas; Forst Thomas
Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathy.
Diabetes technology & therapeutics 2004;6(5):601-6.
2004: Forst T; Standl E; Hohberg C; Konrad T; Schulze J; Strotmann H J; Lübben G; Pahler S; Bachinger A; Langenfeld M; Pfützner A
IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(10):1149-53.
2004: Pfützner Andreas; Caduff Andreas; Larbig Martin; Schrepfer Thomas; Forst Thomas
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoring.
Diabetes technology & therapeutics 2004;6(4):435-41.
2004: Forst T; Nguyen M; Forst S; Disselhoff B; Pohlmann T; Pfützner A
Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device.
Diabetes, nutrition & metabolism 2004;17(3):163-8.
2004: Pfützner Andreas; Pfützner Anke H; Larbig Martin; Forst Thomas
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.
Diabetes technology & therapeutics 2004;6(3):405-12.
2004: Pfützner Andreas; Pfützner Anke H; Larbig Martin; Forst Thomas
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.
Diabetes technology & therapeutics 2004;6(3):405-12.
2004: Pfützner Andreas; Kunt Thomas; Hohberg Cloth; Mondok Agnes; Pahler Sabine; Konrad Thomas; Lübben Georg; Forst Thomas
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
Diabetes care 2004;27(3):682-7.
2004: Forst Th; Pfützner A
[The diagnosis of an autonomic dysfunction of the lower limb as a major aspect of the neurological investigation and risk assessment of a diabetic foot syndrome]
MMW Fortschritte der Medizin 2004;146(3-4):35-8.
2004: Pfützner Andreas; Kann Peter H; Pfützner Anke H; Kunt Thomas; Larbig Martin; Weber Matthias M; Forst Thomas
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
Clinical laboratory 2004;50(9-10):567-73.
2004: Pfützner Andreas; Kann Peter H; Pfützner Anke H; Kunt Thomas; Larbig Martin; Weber Matthias M; Forst Thomas
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
Clinical laboratory 2004;50(9-10):567-73.
2004: Weise A; Grundler S; Zaumsegel D; Klotzek M; Gröndahl B; Forst T; Pfützner A
Development and evaluation of a rapid and reliable method for cytochrome P450 2C8 genotyping.
Clinical laboratory 2004;50(3-4):141-8.
2003: Wallerath Thomas; Kunt Thomas; Forst Thomas; Closs Ellen I; Lehmann Ralf; Flohr Thomas; Gabriel Matthias; Schäfer Dirk; Göpfert Andrea; Pfützner Andreas; Beyer Jürgen; Förstermann Ulrich
Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2003;9(2):95-102.
2003: Pfützner Andreas; Kunt Thomas; Langenfeld Matthias; Löbig Mirjam; Knesovic Maja; Forst Thomas
Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(9):1234-8.
2003: Larbig M; Forst T; Mondok A; Forst S; Pfützner A
Investigation on the accuracy of the blood glucose monitoring device Prestige IQ.
Diabetes, nutrition & metabolism 2003;16(4):257-61.
2003: Pfützner A; Flacke F; Pohl R; Linkie D; Engelbach M; Woods R; Forst T; Beyer J; Steiner S S
Pilot study with technosphere/PTH(1-34)--a new approach for effective pulmonary delivery of parathyroid hormone (1-34).
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(5):319-23.
2003: Pfützner Andreas; Löbig Mirjam; Fortunato Antonio; Forst Thomas
Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid).
Clinical laboratory 2003;49(5-6):227-32.
2003: Pfützner Andreas; Langenfeld Matthias; Kunt Thomas; Löbig Mirjam; Forst Thomas
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
Clinical laboratory 2003;49(11-12):571-6.
2002: Pfützner Andreas; Hermanns Norbert; Schröder Stefan; Wegenstein Margarethe; Larbig Martin; Mondok Agnes; Forst Thomas; Haak Thomas
Cross-sectional investigation on the accuracy of alternate site glucose testing using the Soft-Sense glucose meter.
Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2002;132(25-26):351-7.
2002: Forst T; Pohlmann T; Kunt T; Goitom K; Schulz G; Löbig M; Engelbach M; Beyer J; Pfützner A
The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy.
Acta diabetologica 2002;39(1):1-6.
2002: Pfützner Andreas; Forst Thomas
Response to Jungheim and Koschinsky.
Diabetes care 2002;25(3):638-9; author reply 639-40.
2002: Steiner S; Pfützner A; Wilson B R; Harzer O; Heinemann L; Rave K
Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2002;110(1):17-21.
2002: Pfützner Andreas; Mann Alfred E; Steiner Solomon S
Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.
Diabetes technology & therapeutics 2002;4(5):589-94.
2001: Pfützner A; Forst T; Engelbach M; Margin T; Goitom K; Löbig M; Beyer J; Kunt T
The influence of isolated small nerve fibre dysfunction on microvascular control in patients with diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2001;18(6):489-94.
2001: Rave K; Heise T; Pfützner A; Heinemann L; Sawicki P T
Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.
Diabetes care 2001;24(5):886-90.
2000: Pfützner A; Berger S; Spinas G
[Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus]
Schweizerische medizinische Wochenschrift 2000;130(48):1854-61.
2000: Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
The Journal of clinical endocrinology and metabolism 2000;85(5):1890-4.
2000: Forst T; De La Tour D D; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson B L; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Clinical science (London, England : 1979) 2000;98(3):283-90.
2000: Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]
Deutsche medizinische Wochenschrift (1946) 2000;125(3):37-44.
2000: Kunt T; Forst T; Schmidt S; Pfützner A; Schneider S; Harzer O; Löbig M; Engelbach M; Goitom K; Pohlmann T; Beyer J
Serum levels of substance P are decreased in patients with type 1 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(3):164-7.
2000: Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
Clinical laboratory 2000;46(5-6):275-9.
1999: Engelbach M; Forst T; Hankeln T; Tratzky M; Heerdt S; Pfützner A; Kann P; Kunt T; Schneider S; Schmidt E R; Beyer J
Germline mutations in the MEN1 gene: creation of a new splice acceptor site and insertion of 7 intron nucleotides into the mRNA.
International journal of molecular medicine 1999;4(5):483-5.
1999: Renner R; Pfützner A; Trautmann M; Harzer O; Sauter K; Landgraf R
Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
Diabetes care 1999;22(5):784-8.
1999: Kunt T; Schneider S; Pfützner A; Goitum K; Engelbach M; Schauf B; Beyer J; Forst T
The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
Diabetologia 1999;42(4):465-71.
1999: Kunt T; Forst T; Früh B; Flohr T; Schneider S; Harzer O; Pfützner A; Engelbach M; Löbig M; Beyer J
Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(4):252-6.
1998: Engelbach M; Heerdt S; Görges R; Kunt T; Pfützner A; Forst T; Diefenbach K; Walgenbach S; Beyer J
Is there an ectopic secretion of monomeric calcitonin in the human being?
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1998;383(6):456-9.
1998: Forst T; Kunt T; Pohlmann T; Goitom K; Engelbach M; Beyer J; Pfützner A
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.
The Journal of clinical investigation 1998;101(10):2036-41.
1998: Forst T; Pfützner A; Kunt T; Pohlmann T; Schenk U; Bauersachs R; Küstner E; Beyer J
Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation.
Clinical science (London, England : 1979) 1998;94(3):255-61.
1998: Forst T; Kunt T; Pohlmann T; Goitom K; Löbig M; Engelbach M; Beyer J; Pfützner A
Microvascular skin blood flow following the ingestion of 75 g glucose in healthy individuals.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1998;106(6):454-9.
1998: Forst T; Kunt T; Pfützner A; Beyer J; Wahren J
New aspects on biological activity of C-peptide in IDDM patients.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1998;106(4):270-6.
1998: Kunt T; Forst T; Harzer O; Buchert G; Pfützner A; Löbig M; Zschäbitz A; Stofft E; Engelbach M; Beyer J
The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1998;106(3):183-8.
1997: Piepkorn B; Kann P; Forst T; Andreas J; Pfützner A; Beyer J
Bone mineral density and bone metabolism in diabetes mellitus.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1997;29(11):584-91.
1997: Forst T; Pfützner A; Bauersachs R; Arin M; Bach B; Biehlmaier H; Küstner E; Beyer J
Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot.
Journal of diabetes and its complications 1997;11(5):291-7.
1997: Stiller R; Gudat U; Pfützner A; Trautmann M E; Haslbeck M
Postprandial treatment with Lispro insulin.
Diabetes & metabolism 1997;23(3):232-3.
1996: Henrichs H R; Unger H; Trautmann M E; Pfützner A
Severe insulin resistance treated with insulin lispro.
Lancet 1996;348(9036):1248.
1996: Forst T; Pfützner A; Jahn C; Schmitz H; Lichtwald K; Beyer J; Lehnert H
Decreased sympatho-adrenal activity in diabetic patients with autonomic dysfunction following mental stress.
Journal of the autonomic nervous system 1996;61(1):31-6.
1996: Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann M E; Haslbeck M; Schatz H; Beyer J
Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1996;104(1):25-30.
1995: Forst T; Pfützner A; Kann P; Schehler B; Lobmann R; Schäfer H; Andreas J; Bockisch A; Beyer J
Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(10):874-9.
1995: Ambrosch A; Pfützner A; Ponder B A; Beyer J; Luley C; Lehnert H
[Multiple endocrine neoplasia type 2a. Genetic screening in the familial tumor syndrome]
Deutsche medizinische Wochenschrift (1946) 1995;120(17):615-9.
1995: Forst T; Beyer J; Cordes U; Pfützner A; Küstner E; Moll R; Bockisch A; Lehnert H
Gynaecomastia in a patient with a hCG producing giant cell carcinoma of the lung. Case report.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1995;103(1):28-32.
1995: Forst T; Pfützner A; Kann P; Lobmann R; Schäfer H; Beyer J
Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesions.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1995;103(2):94-8.
1995: Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1995;103(2):123-5.
1994: Forst T; Kann P; Pfützner A; Lobmann R; Schäfer H; Beyer J
Association between "diabetic thick skin syndrome" and neurological disorders in diabetes mellitus.
Acta diabetologica 1994;31(2):73-7.
1993: Pfützner A; Forst T; Kann P; Beyer J
[Driver's license and diabetes. Legal and social medicine aspects]
Versicherungsmedizin / herausgegeben von Verband der Lebensversicherungs-Unternehmen e.V. und Verband der Privaten Krankenversicherung e.V 1993;45(5):149-51.
1993: Kann P; Schulz U; Nink M; Pfützner A; Schrezenmeir J; Beyer J
Architecture in cortical bone and ultrasound transmission velocity.
Clinical rheumatology 1993;12(3):364-7.
1989: Edenharder R; Pfützner A; Hammann R
Characterization of NAD-dependent 3 alpha- and 3 beta-hydroxysteroid dehydrogenase and of NADP-dependent 7 beta-hydroxysteroid dehydrogenase from Peptostreptococcus productus.
Biochimica et biophysica acta 1989;1004(2):230-8.
1988: Edenharder R; Pfützner A
Characterization of NADP-dependent 12 beta-hydroxysteroid dehydrogenase from Clostridium paraputrificum.
Biochimica et biophysica acta 1988;962(3):362-70.

Sign-in to see more